For: | Tu W, Ye J, Wang ZJ. Embryonic liver fordin is involved in glucose glycolysis of hepatic stellate cell by regulating PI3K/Akt signaling. World J Gastroenterol 2016; 22(38): 8519-8527 [PMID: 27784964 DOI: 10.3748/wjg.v22.i38.8519] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v22/i38/8519.htm |
Number | Citing Articles |
1 |
Zhen Zhao, Chien-Yu Lin, Kun Cheng. siRNA- and miRNA-based therapeutics for liver fibrosis. Translational Research 2019; 214: 17 doi: 10.1016/j.trsl.2019.07.007
|
2 |
Feng Xu, Huan Xu, Zixiong Li, Yuanyuan Huang, Xiaoling Huang, Yangyi Li, Xiaohe Zheng, Yongsong Chen, Ling Lin. Glycolysis-Based Genes Are Potential Biomarkers in Thyroid Cancer. Frontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.534838
|
3 |
Anirban Goutam Mukherjee, Uddesh Ramesh Wanjari, Abilash Valsala Gopalakrishnan, Ramkumar Katturajan, Sandra Kannampuzha, Reshma Murali, Arunraj Namachivayam, Raja Ganesan, Kaviyarasi Renu, Abhijit Dey, Balachandar Vellingiri, Sabina Evan Prince. Exploring the Regulatory Role of ncRNA in NAFLD: A Particular Focus on PPARs. Cells 2022; 11(24): 3959 doi: 10.3390/cells11243959
|
4 |
Filipa Lopes-Coelho, Carolina Nunes, Sofia Gouveia-Fernandes, Rita Rosas, Fernanda Silva, Paula Gameiro, Tânia Carvalho, Maria Gomes da Silva, José Cabeçadas, Sérgio Dias, Luís G. Gonçalves, Jacinta Serpa. Monocarboxylate transporter 1 (MCT1), a tool to stratify acute myeloid leukemia (AML) patients and a vehicle to kill cancer cells. Oncotarget 2017; 8(47): 82803 doi: 10.18632/oncotarget.20294
|
5 |
Ming-Ling Chang, Sien-Sing Yang. Metabolic Signature of Hepatic Fibrosis: From Individual Pathways to Systems Biology. Cells 2019; 8(11): 1423 doi: 10.3390/cells8111423
|
6 |
Ming Qiao, Jianhua Yang, Yi Zhu, Yao Zhao, Junping Hu. Transcriptomics and proteomics analysis of system-level mechanisms in the liver of apigenin-treated fibrotic rats. Life Sciences 2020; 248: 117475 doi: 10.1016/j.lfs.2020.117475
|
7 |
Ruirui Gui, Wanqiao Li, Zhipeng Li, Hongbin Wang, Yuchen Wu, Wenlin Jiao, Gang Zhao, Yannan Shen, Luping Wang, Jialu Zhang, Sihan Chen, Linlin Hao, Yunyun Cheng. Effects and potential mechanisms of IGF1/IGF1R in the liver fibrosis: A review. International Journal of Biological Macromolecules 2023; 251: 126263 doi: 10.1016/j.ijbiomac.2023.126263
|
8 |
Xue-Qing Hu, Ya-Nan Song, Rong Wu, Fei-Fei Cai, Yongyu Zhang, Jing-Hua Peng, Yi-Yang Hu, Shi-Bing Su. Metabolic mechanisms of Fuzheng-Huayu formula against liver fibrosis in rats. Journal of Ethnopharmacology 2019; 238: 111888 doi: 10.1016/j.jep.2019.111888
|
9 |
Puyang Gong, Kehuan Yin, Xiaomin Luo, Jian Gu, Rui Tan, Yan Wu, Dapeng Li. Tandem mass tag-based proteomics analysis reveals the multitarget mechanisms of Phyllanthus emblica against liver fibrosis. Frontiers in Pharmacology 2022; 13 doi: 10.3389/fphar.2022.989995
|
10 |
Ali Mahmoudi, Stephen L. Atkin, Tannaz Jamialahmadi, Maciej Banach, Amirhossein Sahebkar. Effect of Curcumin on Attenuation of Liver Cirrhosis via Genes/Proteins and Pathways: A System Pharmacology Study. Nutrients 2022; 14(20): 4344 doi: 10.3390/nu14204344
|
11 |
Yi Zhu, Ming Qiao, Jianhua Yang, Junping Hu, Jun Yan Tao. Elucidating the Mechanisms of Hugan Buzure Granule in the Treatment of Liver Fibrosis via Network Pharmacology. Evidence-Based Complementary and Alternative Medicine 2020; 2020(1) doi: 10.1155/2020/8385706
|